BF
USNA icon

BOK Financial’s Usana Health Sciences USNA Stock Holding History

BOK Financial’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,560
Closed -$162K – 1457
2024
Q3 		$162K Sell
4,560
-966
-17% -$39.7K ﹤0.01% 712
2024
Q2 		$250K Buy
5,526
+2,755
+99% +$127K ﹤0.01% 732
2024
Q1 		$133K Buy
2,771
+2,031
+274% +$99.5K ﹤0.01% 765
2023
Q4 		$39.7K Sell
740
-852
-54% -$43.1K ﹤0.01% 826
2023
Q3 		$72.5K Buy
1,592
+184
+13% +$11.5K ﹤0.01% 739
2023
Q2 		$88.8K Sell
1,408
-301
-18% -$19.2K ﹤0.01% 737
2023
Q1 		$107K Buy
+1,709
New +$102K ﹤0.01% 740

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BOK Financial's USNA Position: Q4 2024 in Review

BOK Financial sold out of Usana Health Sciences (USNA) in Q4 2024, closing a stake of 4,560 shares — an estimated $162K sold.

BOK Financial first reported a position in USNA in Q1 2023 and held it in 7 quarters. The position peaked at $250K in Q2 2024. 152 funds tracked by Wall St. Rank hold USNA as of Q4 2024.

  • BOK Financial reported no remaining Usana Health Sciences position as of Q4 2024 after selling out during the quarter.
  • BOK Financial sold 4,560 Usana Health Sciences shares in Q4 2024, an estimated $162K.
  • BOK Financial first reported a position in Usana Health Sciences in Q1 2023 and held it in 7 quarters.
  • BOK Financial's Usana Health Sciences position peaked at $250K in Q2 2024.
  • 152 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2024.

Based on BOK Financial's 13F filing for Q4 2024, filed 14 Feb 2025.